BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35253306)

  • 41. The miR-106b/NR2F2-AS1/PLEKHO2 Axis Regulates Migration and Invasion of Colorectal Cancer through the MAPK Pathway.
    Liu S; An G; Cao Q; Li T; Jia X; Lei L
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA PSMA3-AS1 promotes colorectal cancer cell migration and invasion via regulating miR-4429.
    Peng P; Wang Y; Wang BL; Song YH; Fang Y; Ji H; Huangfu CN; Wang KM; Zheng Q
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11594-11601. PubMed ID: 33275226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro.
    Wen H; Li Z; Song S; Xu L; Tong X; Yan H
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):446-453. PubMed ID: 33637977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
    Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
    Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
    [No Abstract]   [Full Text] [Related]  

  • 46. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression.
    Feng Y; Dong Y; Rao B; Yu Y; Su W; Zeng J; Zhao E; Chen Y; Fang S; Zhou Y; Lu J; Qiu F
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14927-14940. PubMed ID: 37603104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.
    Chen G; Gu Y; Han P; Li Z; Zhao JL; Gao MZ
    J Cell Physiol; 2019 Aug; 234(10):18688-18696. PubMed ID: 30912164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells.
    Wu X; Pang Q; Zhi F; Mao X; Hu Y
    Tissue Cell; 2022 Jun; 76():101769. PubMed ID: 35325674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 53. LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.
    Ma YN; Hong YG; Yu GY; Jiang SY; Zhao BL; Guo A; Wang Y; Cui XM; Hao LQ; Zheng H
    Cancer Cell Int; 2021 Sep; 21(1):501. PubMed ID: 34535128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.
    Kong WQ; Liang JJ; Du J; Ye ZX; Gao P; Liang YL
    Cancer Biother Radiopharm; 2021 Nov; 36(9):753-764. PubMed ID: 32379493
    [No Abstract]   [Full Text] [Related]  

  • 56. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
    Yang X; Duan B; Zhou X
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3.
    Zhou Y; Shao Y; Hu W; Zhang J; Shi Y; Kong X; Jiang J
    Cell Death Differ; 2023 Jan; 30(1):111-124. PubMed ID: 35978049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
    Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
    FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
    Tian JB; Cao L; Dong GL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.